SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Capital Markets Event

2 Nov 2022 07:00

RNS Number : 9884E
Rotork PLC
02 November 2022
Β 

Β 

2 November 2022

Rotork plc

Β 

Capital Markets Event - Achieving our ambition through Growth+

Β 

Rotork plc ("Rotork"), the global flow control and instrumentation group, is this afternoon hosting a Capital Markets Event ("CME")Β to outline its new Growth+ strategy.

Β 

The Growth+ strategy is designed to deliver our growth ambition through our three pillars of Target Segments, Customer Value, and Innovative Products and Services, each underpinned by our 'Enabling a Sustainable Future' initiative.

Β 

The CME will include presentations from Kiet Huynh, Chief Executive Officer, Jonathan Davis, Finance Director, and senior Rotork executives, and will also cover the megatrends of automation, electrification and digitalisation which are expected to benefit all of our markets and further support our growth. In addition, the CME will highlight Rotork Site Services, a key differentiator within our industry, with the potential for above group average growth and returns.

Β 

Rotork's target segments span the divisions and are expected to grow faster than underlying markets, supporting our ambition to deliver mid to high single-digit revenue growth and mid 20s adjusted operating margins over time.

Β 

No update on trading will be provided at the CME. Rotork will issue an update on trading for the four months to 30 October 2022 on 23 November 2022.

Β 

Presentations will be made available on the company's website later today at https://www.rotork.com/en/investors and a recording of the CME will be available in due course.

Β 

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Andrew Carter, Investor Relations Director

Β 

FTI Consulting Tel: +44 (0)20 3727 1340

Nick Hasell / Susanne Yule

Β 

About Rotork

Rotork is a market-leading global provider of mission-critical intelligent flow control solutions for oil & gas, water and wastewater, power, chemical, process and industrial applications. We help customers around the world to improve efficiency, reduce emissions, minimise their environmental impact and assure safety. Rotork employs about 3,200 people, has manufacturing facilities in 17 locations and serves 170 countries through a global service network. Its shares have a premium listing on the London Stock Exchange (symbol: ROR) and are a constituent of the FTSE 250 index. For more information please visitΒ www.rotork.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCUAUWRUUUARAA
Date   Source Headline
11th Jun 202612:08 pmRNSDirector/PDMR Shareholding
1st Jun 20269:34 amRNSTotal Voting Rights
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20265:57 pmRNSDirector/PDMR Shareholding
12th May 202612:25 pmRNSDirector/PDMR Shareholding
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:45 amRNSResult of AGM
1st May 20269:53 amRNSTotal Voting Rights
1st May 20267:00 amRNSTrading update
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202610:49 amRNSDirector/PDMR Shareholding
21st Apr 20264:58 pmRNSHolding(s) in Company
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20263:18 pmRNSDirector/PDMR Shareholding
15th Apr 20261:19 pmRNSShare buyback programme
13th Apr 20264:37 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20268:52 amRNSDirector/PDMR Shareholding
7th Apr 20269:52 amRNSTransaction in Own Shares - Clarification Notice
7th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:10 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20263:03 pmRNS2025 Annual Report and Notice of 2026 AGM
26th Mar 20261:55 pmRNSDirector/PDMR Shareholding
25th Mar 202611:36 amRNSDirector/PDMR Shareholding
23rd Mar 20262:38 pmRNSHolding(s) in Company
23rd Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 202611:01 amRNSDirector/PDMR Shareholding
13th Mar 20261:54 pmRNSShare buyback programme
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 full year results
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20261:16 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.